Skip to main content
. 2012 Jul;5(4):232–240.

Table 3.

Pharmacokinetic Properties of 5-HT3 Receptor Antagonists

Agent Ondansetron Granisetron Dolasetron Palonosetron
Half-life (hrs) 3–4 7–9 7–8 40
Oral bioavailability, % 56 60 75 N/A
Renal elimination, % 5 12 67 42
Hepatic metabolism CYP-3A, CYP-1A, CYP-2D6, CYP-2E1 CYP-3A CYP-3A, CYP-2D6 CYP-3A4, CYP-2D6, CYP-1A2

5-HT indicates serotonin; CYP, cytochrome P; N/A, not applicable.